Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent D959015 COVID immunoassay test device

Patent D959015 was granted and assigned to Zhejiang Orient Gene Biotech on July, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Zhejiang Orient Gene Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

D959015

Patent Inventor Names

Jianqiu Fang0

Hua Zhang0

Siyu Lei0

Date of Patent

July 26, 2022

Patent Application Number

29745986

Date Filed

August 13, 2020

Patent Citations Received

‌

US Patent D1025392 Test device

‌

US Patent D990704 Test strip for medical or laboratory purposes

‌

US Patent D999931 Medical diagnostic device

‌

US Patent D1013537 Medical test kit

‌

US Patent D1013536 Medical test kit

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent D959015 COVID immunoassay test device

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API